ArticleNanophotonics (Berlin, Germany)2024
Nanoantenna induced liquid crystal alignment for high performance tunable metasurface.
Article in Nanophotonics (Berlin, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Meta-optics redefines microdisplay: monolithic color LCoS without polarization dependency.Nature communications · 2025Article
- Electrically Tunable Geometric-Phase Optical Element with Hybrid Retardation and Subwavelength Pixel Size Enabled by Metasurface-Induced Liquid Crystal Patterning.ACS applied optical materials · 2025Article
- From blue to red color wavelength complex modulation characteristics of liquid crystal on a metasurface device.Scientific reports · 2025Article
- Spatially Controlled All-Optical Switching of Liquid-Crystal-Empowered Metasurfaces.ACS photonics · 2025Article
- Programmable nano-optics and photonics.Nanophotonics (Berlin, Germany) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Liquid crystal (LC) based spatial light modulators (SLMs) are a type of versatile device capable of arbitrarily reconfiguring the wavefront of light. For current commercial LC-SLM devices, the large pixel size limits their application to diffractive optics and 3D holographic displays. Pixel miniaturization of these devices is challenging due to emerging inter-pixel crosstalk, ultimately linked to the thick LC layer necessary for full phase (or amplitude) control. Integration of metasurfaces, i.e., 2D arrangements of resonant nanoantennas, with thin LC has emerged as a promising platform to boost light modulation, enabling realization of sub-wavelength pixel size SLMs with full phase (or amplitude) control. In most devices realized so far, however, the presence of an alignment layer, necessary to induce a preferential initial LC orientation, increases the voltage requirement for resonance tuning and reduces the efficiency of light modulation, something that accentuates for an ultra-thin (e.g., submicron) metasurface-LC cell. Here, we present an alternative strategy by which the LC molecular alignment is purely controlled by the periodicity and geometry of the nanoantenna without any additional alignment layer. The nanoantennas are specifically designed for the double purpose of sustaining optical resonances that are used for light modulation and to, simultaneously, induce the required LC pre-alignment. The proposed device structure allows lower voltage and reduced switching times (sub-millisecond) compared to devices including the alignment layer. This novel strategy thus helps to improve the performance of these miniaturized-pixel devices, which have emerged as one of the potential candidates for the next generation of products in a wide range of applications, from virtual/augmented reality (VR/AR) and solid-state light detection and ranging (LiDAR), to 3D holographic displays and beyond.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.